Skip to content

Clinical trials

Lung Diseases, Interstitial trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: New Zealand Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20223
20231
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics3
Avalyn Pharma Inc.1
Boehringer Ingelheim1
Contineum Therapeutics1
Insmed Incorporated1
Kyntra Bio1
Pulmovant, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial9
Idiopathic Pulmonary Fibrosis4
Pulmonary Fibrosis3
Hypertension, Pulmonary2
Alveolitis, Extrinsic Allergic1
Cardiovascular Diseases1
Fibrosis1
Idiopathic Interstitial Pneumonias1
Lung Diseases1
Vascular Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.